Follow
Mesenchymal Stromal Cells
Mesenchymal Stromal Cells: are the spindle shaped plastic-adherent cells isolated from bone marrow. They have been the focus of intense research due to their unique features and self-renewing capability. They can be separated into various lineages, which makes them highly probable for clinical application in cell-based therapies.
DEC 01, 2020 | 1:00 PM
DATE: December 1st, 2020 TIME: 01:00 PM - PDT, 3:00 PM - Bogotá / Ciudad de México, 5:00 PM - Buenos Aires / Sao Paulo La anemia es un trastorno que afecta principalmente c&eac...
SEP 23, 2020 | 9:00 AM
Extracellular vesicles (EVs) are nanosized vesicles containing active proteins, lipids, and different types of genetic material such as non coding RNA species, related to the characteristics...
JUN 23, 2020 | 10:00 AM
DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
MAY 23, 2019 | 9:00 AM
DATE: May 23, 2019TIME: 9:00am PDT, 12:00pm EDT Although mesenchymal stem/stromal cells (MSCs) chondrogenic differentiation has been thoroughly investigated...
MAY 16, 2019 | 12:00 PM
DATE: May 16, 2019TIME: 12:00 PM PDT Mesenchymal stem or stromal cells (MSCs) are a promising resource for cell-based therapies and are being tested in already registered phase...
OCT 26, 2017 | 12:00 PM
DATE: October 26, 2017TIME: 12:00 PM PDTThis presentation will focus on recent advances in cellular therapy—from mesenchymal stromal cells (MSCs) to tumor-specific T-cells. More s...
AUG 30, 2016 | 8:00 AM
Buerger’s disease, commonly known as Thromboangiitis obliterans, is a non-atherosclerotic, segmental inflammatory disease that can affect the small and medium-sized arteries of young pe...
AUG 30, 2016 | 8:00 AM
Autologous cell based interventions, which include mesenchymal stem cells, are mostly unproven therapies increasingly being applied for musculoskeletal and other medical disorders by medical ...
AUG 30, 2016 | 8:00 AM
Mesenchymal stromal cell (MSC) therapy is a promising option to support endogenous regeneration and immunomodulation. However, the clinical results are contradictory. We think that the recent...
JAN 26, 2015 | 8:00 AM
Advances in stem cell biology have raised great expectations that diseases of the central nervous system may be ameliorated by the development of non-haematopoietic stem cell medicines. Yet,...
AUG 30, 2016 | 8:00 AM
Buerger’s disease, commonly known as Thromboangiitis obliterans, is a non-atherosclerotic, segmental inflammatory disease that can affect the small and medium-sized arteries of young pe...